This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Delivered as Hybrid Event from 15-17 November 2021
Live In-Person Conference Delivered 15-17 NovemberSheraton Airport Brussels, Belgium

Hangwen Li
Chairman and CEO at Stemirna Therapeutics

Profile

Dr. Hangwen Li is the founder, chairman and CEO of Stemirna Therapeutics. He received his Ph.D degree in Cancer Biology from MD Anderson Cancer center of the University of Texas in 2010. Dr. Hangwen Li had nearly 20 years of research and treatment experience in the fields of tumor immunotherapy, RNA drugs and cancer stem cells, and had worked in clinical departments in the United States. He had worked in one of the best cancer hospital and tumor cell immunity center in the United States, and had won two awards for clinical transformation from the US Department of Defense. Currently he is an assistant professor in the Department of Pharmacology and Therapeutics of Roswell Cancer Center and also an expert in translational Medicine platform of Oriental Hospital affiliated to Tongji University in Shanghai.

Agenda Sessions

  • A Commercial Manufacturing Solution for COVID-19 Vaccine in Large Scale

    10:30

Speakers at this event